Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Cohen

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Biotechnology|April 7, 2011
Targeting voltage-gated sodium channels for treating neuropathic and inflammatory painCharles J Cohen
Biochemical Pharmacology|January 9, 2018
Integration of biological/pathophysiological contexts to help clarify genotype-phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case studyRaymond J Winquist, Charles J Cohen
Pharmaceutical Patent Analyst|November 7, 2014
Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010Shaoyi Sun, Charles J Cohen, Christoph M Dehnhardt
Medicine, Health Care, and Philosophy|June 27, 2014
Social values as an independent factor affecting end of life medical decision makingCharles J Cohen, Yifat Chen, Hedi Orbach, et al.
The Journal of Biological Chemistry|October 27, 2004
Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cellsMark E Williams, Bill Burton, Arturo Urrutia, et al.
Pain|January 18, 2014
Letter to the editorYigal Paul Goldberg, Charles J Cohen, Rostam Namdari, et al.
The Journal of Clinical Investigation|May 23, 2017
Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitabilityJianying Huang, Carlos G Vanoye, Alison Cutts, et al.
Frontiers in Pharmacology|April 25, 2025
The venom of <i>Cyriopagopus schmidti</i> spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potentialAurélie Antunes, Jérôme Montnach, Kuldip Khakh, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2014
The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7Shaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitorsTania Chernov-Rogan, Tianbo Li, Gang Lu, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Biotechnology|April 7, 2011
Targeting voltage-gated sodium channels for treating neuropathic and inflammatory painCharles J Cohen
Biochemical Pharmacology|January 9, 2018
Integration of biological/pathophysiological contexts to help clarify genotype-phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case studyRaymond J Winquist, Charles J Cohen
Pharmaceutical Patent Analyst|November 7, 2014
Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010Shaoyi Sun, Charles J Cohen, Christoph M Dehnhardt
Medicine, Health Care, and Philosophy|June 27, 2014
Social values as an independent factor affecting end of life medical decision makingCharles J Cohen, Yifat Chen, Hedi Orbach, et al.
The Journal of Biological Chemistry|October 27, 2004
Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cellsMark E Williams, Bill Burton, Arturo Urrutia, et al.
Pain|January 18, 2014
Letter to the editorYigal Paul Goldberg, Charles J Cohen, Rostam Namdari, et al.
The Journal of Clinical Investigation|May 23, 2017
Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitabilityJianying Huang, Carlos G Vanoye, Alison Cutts, et al.
Frontiers in Pharmacology|April 25, 2025
The venom of <i>Cyriopagopus schmidti</i> spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potentialAurélie Antunes, Jérôme Montnach, Kuldip Khakh, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2014
The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7Shaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitorsTania Chernov-Rogan, Tianbo Li, Gang Lu, et al.
Pageof 3